ePharma West Session Spotlight: The Evolution of New are Delivery Models & Their Effects on Pharma Marketing

Now more than ever before, doctors have less control over what’s prescribed. They’re feeling pressure to prove the financial value of a branded drug over a generic and can have to justify choices to upper management. The whole pharma-HCP-consumer model is changing, and marketers need to adapt their messaging to address this changing, challenging landscape. Doctors must be armed with information on how the product provides value by decreasing readmissions and lowering other costs. Speaker Mike Strong In this week's ePharma Summit West session spotlight, we highlight this is the session  The Evolution of New are Delivery Models & Their Effects on Pharma Marketing.  ePharma Summit West will be taking place September 16-18, 2013 in downtown San Francisco.  For more information on this session and the rest of the program, download the agenda.  As a reader of this blog, when you register to join us and mention code XP1856BLOG, you'll save 15% off the standard rate! Featured Session:  The Evolution of New are Delivery Models & Their Effects on Pharma Marketing Featured Speakers: Jeff Landau, Director Strategic Marketing & Corporate Development, Threshold Pharmaceuticals Mike Strong, Health Systems Manager, Novo Nordisk Patti Peeples, RPh, PhD, CEO and Founder, HealthEconomics.Com About the session: Although the term “ACO,” or accountable care organizations, are not something new, we’re just now starting to see ACOs i...
Source: ePharma Summit - Category: Medical Marketing and PR Tags: pharmaceutical marketing pharma marketing Healthcare Delivery Models ePharma Summit Wets Source Type: blogs